BioSpace News Archive

Business

CDRD and Pfizer Canada Partner to Establish The CDRD Life Sciences Executive Institute

The Centre for Drug Research and Development (CDRD) and Pfizer Canada announced the launch of the CDRD Executive Institute under the umbrella of The CDRD Academy.

May 2, 2018

·

5 min read

Pharm Country

Bristol-Myers Squibb and Biogen Are the Pharmas Most Trusted by Doctors, Study Finds

Doctors surveyed for Taking the Pulse® U.S., the longest-running U.S. study of online physician attitudes and multichannel behaviors, rated Bristol-Myers Squibb and Biogen as the most “trusted partners” based on recent digital interactions.

May 2, 2018

·

4 min read

FDA

Cellectis Files IND for UCART22 in Acute Lymphoblastic Leukemia (B-ALL)

Cellectis announced that the Company has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) requesting approval to initiate a Phase 1 clinical trial for UCART22.

May 2, 2018

·

4 min read

Deals

Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder

Medpace Holdings, Inc. announced a secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited.

May 2, 2018

·

2 min read

BioForest

Tully Isn’t Real - But Postpartum Depression Sure Is

The film Tully, starring Charlize Theron and Mackenzie Davis, has been greatly anticipated by audiences hoping for an honest look at motherhood.

May 2, 2018

·

3 min read

FDA

TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S announced the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application for TRINTELLIX® (vortioxetine).

May 2, 2018

·

13 min read

FDA

More Progress on LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment

The U.S. Food and Drug Administration (FDA) granted tisagenlecleucel (Kymriah®) its second approval to treat patients with diffuse large B-cell lymphoma (DLBCL).

May 2, 2018

·

3 min read

BioMidwest

Discovery Could Lead To Personalized Medical Therapies for Emerging New Food Allergy Disorder

Scientists at Cincinnati Children’s Hospital Medical Center have uncovered three distinct subtypes of eosinophilic esophagitis (EoE), an emerging food allergic disease.

May 2, 2018

·

3 min read

Policy

Lawmakers Urged to Recognize Importance of Young Children at First 5 Advocacy Day

First 5 commissions representing counties throughout California gathered at the State Capitol today to celebrate the 20th anniversary of voters’ passage of Proposition 10.

May 2, 2018

·

3 min read

Pharm Country

New Youth Mental Health Assessment Offers Providers a Solution for Monitoring Children’s Mental Health

Tridiuum has announced the national application of its youth-focused mental health assessment tool, Youth MH, with the potential to serve thousands of patients across the country.

May 2, 2018

·

3 min read